"Meta ban on health-targeting ads will soon restrict clinical trial recruiters"

“A new ban on “Detailed Targeting” options for advertisers on Facebook and other Meta-owned social media platforms – which includes restricting marketing based on “health causes” – takes effect January 19, and may make it more challenging for health care and life sciences companies to use these platforms to identify individuals with a specific health condition. This could have broad and mixed impacts on social media users; but, it could also raise barriers to identifying patients for beneficial purposes, such as identifying clinical trial participants and those in need of access to telehealth services.”

Read the full article from January 2022 published by JDSUPRA.